Baytown community launches Be Well™ Baytown initiative led by MD Anderson and ExxonMobil
In an effort to improve public health and lower the risk of cancer, Baytown community organizations are partnering with The University of Texas MD Anderson Cancer Center and ExxonMobil to launch Be Well Baytown™. Knowing that more than half of cancers may be prevented by applying knowledge and tools available today, the mission of Be Well Baytown is to promote wellness and lower cancer risk.
Made possible by a $10 million...
Dream Team aims to intercept pancreatic cancer before it flourishes
Deeply entrenched and mature by the time it’s found, pancreatic cancer is one of the hardest to defeat. A Dream Team assembled by Stand...
MD Anderson Hosts A Conversation With a Living Legend® with philanthropist Rich Kinder
Houston philanthropist Rich Kinder, executive chairman of Kinder Morgan Inc., will join Houston-based NBC News correspondent Janet Shamlian...
Drug yields high response rates for lung cancer patients with harsh mutation
A targeted therapy resurrected by the Moon Shots Program™ at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries a highly treatment-resistant mutation.
In a phase 2 clinical trial, the drug poziotinib has shrunk tumors by at least 30 percent in eight of 11 (73 percent) non-small cell lung cancer patients whose cancer...
V. Craig Jordan, Ph.D., elected to the National Academy of Medicine
V. Craig Jordan, Ph.D., professor of Breast Medical Oncology, has been elected to the National Academy of Medicine for his discovery of selective...
Cattlemen for Cancer Research to host annual auction Oct. 21
Cattlemen for Cancer Research (CCR) will hold its 19th annual auction Saturday, Oct. 21 at the Hills Prairie Livestock Auction Company, 1177...
MD Anderson team selected for national push to expand immunotherapy
A major national effort to expand the reach of cancer immunotherapy to benefit more patients will draw upon the expertise of a team of researchers...
MD Anderson expert to lead free Austin panel on Alzheimer’s disease
The University of Texas MD Anderson Cancer Center and Belmont Village Senior Living will present a free panel discussion in Austin exploring...
Registration open for Nov. 11 Boot Walk to End Cancer®
The University of Texas MD Anderson Cancer Center has opened registration for the second annual Boot Walk to End Cancer®, Saturday, Nov...
MD Anderson and BridgeBio Pharma launch Navire Pharma to develop targeted therapy for patients with difficult-to-treat cancer
The University of Texas MD Anderson Cancer Center and BridgeBio Pharma today announced the launch of Navire Pharma, a biopharmaceutical company...